LOVE CANNARA BIOTECH INC.

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- ("Cannara" or the "Company") () ( (), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that the Company has achieved its highest national market share of 3.2% in July 2024 which places Cannara as the 9th largest licensed producer in Canada by market share1.

“We are thrilled to report that July 2024 marks a significant milestone for Cannara, with our highest monthly national retail sales in the Company's history, including an approximate 11.8% market share in Quebec1. This achievement is a testament to the dedication and hard work of our entire team, as well as the growing demand for our premium cannabis products. We look forward to discussing these results in more detail during our upcoming investor webcast, where we will provide further insights into our third quarter of 2024 financial performance and future growth strategies,” commented Nicholas Sosiak, CFO of Cannara.

Cannara will host a live investor webcast on Tuesday, August 20, 2024, at 2:00 PM ET. Nicholas Sosiak, CFO, will lead the presentation, covering key aspects of the business and delivering a detailed update on Q3 2024 financial results. Following the presentation, investors will have the opportunity to participate in an interactive Q&A session.

Date & Time: August 20, 2024, at 2:00 PM ET

Webcast Link:

To listen to the webcast or participate in the live Q&A, please pre-register using the link provided above.

For those unable to attend the live event, an archived version of the webcast and presentation will be available on the Company's investor relations website at .

Contact: 

Nicholas Sosiak, CPA, CA

Chief Financial Officer

  

Zohar Krivorot

President & Chief Executive Officer

  

About Cannara Biotech Inc.

Cannara Biotech Inc. () ( (), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit  .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Cautionary Statement Regarding “Forward-Looking” Information

This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

1 Based on estimated sales data provided by HiFyre Retail Analytics, Licensed Producer Sales Nationally, for the period of July 2024.



EN
16/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CANNARA BIOTECH INC.

 PRESS RELEASE

Cannara Biotech Delivers Highest Revenue and Profitability Since Incep...

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025 Record Revenue: Total revenues, net of excise taxes increased to $27.3 million in Q3 2025, representing a 40% increase over the prior year period.Record Profitability: Gross profit before fair value adjustments rose to $12.1 million in Q3 2025, representing a 110% increase over the prior year period. Gross margin before fair value adjustments rose to 44% in Q3 2025, from 29% in the prior year period.Record Adjusted EBITDA and Adjusted EBITDA Margin: Delivered seventeenth consecutive quarter of posit...

 PRESS RELEASE

Cannara Biotech enregistre son chiffre d’affaires et sa rentabilité le...

Cannara Biotech enregistre son chiffre d’affaires et sa rentabilité les plus élevés depuis sa création au troisième trimestre de l’exercice 2025 Chiffre d’affaires record : le total des produits, déduction faite des taxes d’accise, a augmenté pour atteindre 27,3 millions de dollars au troisième trimestre 2025, soit une hausse de 40 % par rapport à la même période de l’exercice précédent.Rentabilité record : la marge brute avant ajustements de la juste valeur a atteint 12,1 millions de dollars au troisième trimestre 2025, soit une augmentation de 110 % par rapport à la même période de l’exer...

 PRESS RELEASE

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category...

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes MONTREAL, July 24, 2025 (GLOBE NEWSWIRE) -- (“Cannara”, “the Company”, “us” or “we”) () () (), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., is proud to announce the preliminary acceptance by the Société Québécoise du Cannabis (“SQDC”) of five vape cartridge products to be distributed across all Québec retail stores in November 2025 (Q1 FY2026), in addition to b...

 PRESS RELEASE

Cannara obtient 5 inscriptions clés dans la nouvelle catégorie de cart...

Cannara obtient 5 inscriptions clés dans la nouvelle catégorie de cartouches de vapotage de la SQDC, y compris des cartouches de vapotage à base de rosine vivante à venir MONTRÉAL, 24 juill. 2025 (GLOBE NEWSWIRE) -- (« Cannara », « la Société », « nous » ou « notre ») () () (), un producteur verticalement intégré de cannabis de qualité supérieure et de produits dérivés à des prix abordables, disposant de deux méga-installations au Québec d’une superficie de plus de 1 650 000 pieds carrés, est fière d’annoncer l’acceptation préliminaire par la Société québécoise du cannabis (« SQDC ») de c...

 PRESS RELEASE

Cannara Biotech Inc. annoncera ses résultats financiers du troisième t...

Cannara Biotech Inc. annoncera ses résultats financiers du troisième trimestre de l'exercice 2025 le 28 juillet 2025 MONTRÉAL, 21 juill. 2025 (GLOBE NEWSWIRE) -- (« Cannara », « la Société », « nous » ou « notre ») () () (), producteur verticalement intégré de cannabis de qualité supérieure et de produits dérivés à des prix abordables, disposant de deux méga-installations au Québec d’une superficie de plus de 1 650 000 pieds carrés, a annoncé aujourd'hui que la Société publiera ses résultats financiers pour le troisième trimestre de l'exercice clos le 31 mai 2025, le lundi 28 juillet 2025...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch